{"id":17055,"date":"2024-12-19T15:30:53","date_gmt":"2024-12-19T15:30:53","guid":{"rendered":"https:\/\/www.anicecommunication.com\/en\/?p=17055"},"modified":"2024-12-19T15:52:03","modified_gmt":"2024-12-19T15:52:03","slug":"emn2025-multiple-myeloma","status":"publish","type":"post","link":"https:\/\/www.anicecommunication.com\/en\/emn2025-multiple-myeloma\/","title":{"rendered":"EMN2025: The International Conference on Multiple Myeloma in Athens"},"content":{"rendered":"
EMN2025: The 6th edition of the International Conference on Multiple Myeloma will be held in Athens from 10 to 12 April 2025.<\/p>\n
Next spring, from 10 to 12 April, Athens<\/strong> will host EMN2025<\/strong>, the sixth edition of the International Conference of the European Myeloma Network<\/strong>, the network of excellence at European level committed to research and study of treatments for blood neoplasms and multiple myeloma, organised by the network<\/strong> in collaboration with the ER Congressi agency.<\/p>\n Following the success of the 5th edition, which was held in Turin, Italy, in April 2024, the Greek capital is getting ready to become the hub of multiple myeloma research and education<\/strong>, offering haematologists, researchers and practitioners an extraordinary opportunity to learn about innovative treatments and the latest technological and scientific advances in this field.<\/p>\n Athens will host EMN2025, the sixth edition of the International Conference of the European Myeloma Network<\/p><\/div>\n EMN2024 – Turin (Italy), April 2024: Pieter Sonneveld – President EMN<\/p><\/div>\n The local organizers for EMN2025 are Professors Evangelos Terpos and Meletios Athanasios Dimopoulos<\/strong> from Athens, EMN members and key contributors to the network, who conceived the scientific programme together with the other scientific coordinators of the event, Pieter Sonneveld (EMN President), Mario Boccadoro (EMN Vice-President), Annemiek Broijl, Niels van de Donk, Maria Gavriatopoulou, Francesca Gay and Roberto Mina.<\/p>\n <\/p>\n EMN2025 will be a meeting of great significance for all those engaged in the fight against multiple myeloma. Besides holding high-level scientific sessions, the conference promotes international collaboration and research sharing, and provides an opportunity for dialogue between haematologists, physicians, researchers, patient associations and industry leaders.<\/p>\n As in previous years, the Conference will devote special attention to young researchers under 40<\/strong>: they will have an opportunity to submit their abstracts to a panel of experts from all over Europe, who will evaluate them and will award to the best 8 a travel grant covering the expenses to attend the event. The Call For Abstracts is already posted on the official website <\/strong>emn2025.com<\/strong><\/a> and will remain open for submission until 12 January 2025<\/strong>: a unique opportunity to present one\u2019s work at the Conference, exchange views and get valuable feedback from professionals in this field.<\/p>\n The scientific programme <\/strong>includes:<\/p>\n EMN2024 – Turin (Italy), April 2024: Mario Boccadoro Vice-President EMN<\/p><\/div>\n Registration for the conference will open on 23 January 2025, <\/strong>with Early Bird benefits available until 4 April<\/strong>. To submit abstracts, register or view the full programme, soon to be made available, please visit the EMN\u2019s official website<\/strong> emn2025.com<\/strong><\/a>.<\/p>\n The website will also include an option for the accreditation of media<\/strong><\/a> interested in attending the conference.<\/p>\n Download text and images>><\/a><\/strong><\/p>\n 19 December 2024<\/p>\n
<\/a>
<\/a>\n
<\/a>EMN2024 – Turin (Italy), April 2024EMN2025 will focus in particular on clinical trials underway and their possible impact on clinical practice<\/strong>, as well as on major advances in the use of Artificial Intelligence<\/strong>, new prognostic factors for a better characterisation of therapy selection<\/strong>, and the development of treatments increasingly targeted<\/strong> to the needs of individual patients.<\/p>\n
<\/a>
\n